JP Morgan Maintains Overweight on US Physical Therapy, Raises Price Target to $120
Benzinga Newsdesk 1 year ago
NewsPrice TargetAnalyst Ratings
JP Morgan analyst Calvin Sternick maintains US Physical Therapy (NYSE:USPH) with a Overweight and raises the price target from $117 to $120.
JP Morgan analyst Calvin Sternick maintains US Physical Therapy (NYSE:USPH) with a Overweight and raises the price target from $117 to $120.